These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31547271)

  • 1. Effect of Diosmin Administration in Patients with Chronic Venous Disorders on Selected Factors Affecting Angiogenesis.
    Feldo M; Wójciak-Kosior M; Sowa I; Kocki J; Bogucki J; Zubilewicz T; Kęsik J; Bogucka-Kocka A
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31547271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Diosmin on Selected Parameters of Oxygen Homeostasis.
    Feldo M; Wójciak M; Dresler S; Sowa P; Płachno BJ; Samborski D; Sowa I
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a Low-Dose Diosmin Therapy on Improving Symptoms and Quality of Life in Patients with Chronic Venous Disease: Randomized, Double-Blind, Placebo-Controlled Trial.
    Serra R; Ielapi N; Bitonti A; Candido S; Fregola S; Gallo A; Loria A; Muraca L; Raimondo L; Velcean L; Guadagna S; Gallelli L
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33808784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma VEGF as a marker of therapy in patients with chronic venous disease treated with oral micronised flavonoid fraction - a pilot study.
    Shoab SS; Scurr JH; Coleridge-Smith PD
    Eur J Vasc Endovasc Surg; 1999 Oct; 18(4):334-8. PubMed ID: 10550269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diosmin in the treatment of venous disease: pharmacokinetics and pharmacodynamics (in Russian only)].
    Talibov OB
    Khirurgiia (Mosk); 2019; (3):135-140. PubMed ID: 30938369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo.
    Westphal JR; Van't Hullenaar R; Peek R; Willems RW; Crickard K; Crickard U; Askaa J; Clemmensen I; Ruiter DJ; De Waal RM
    Int J Cancer; 2000 Jun; 86(6):768-76. PubMed ID: 10842189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
    Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
    J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of plasma vascular endothelial growth factor to CEAP clinical stage and symptoms in patients with chronic venous disease.
    Howlader MH; Coleridge Smith PD
    Eur J Vasc Endovasc Surg; 2004 Jan; 27(1):89-93. PubMed ID: 14652844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
    Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
    Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise in patients with intermittent claudication elicits signs of inflammation and angiogenesis.
    Palmer-Kazen U; Religa P; Wahlberg E
    Eur J Vasc Endovasc Surg; 2009 Dec; 38(6):689-96. PubMed ID: 19775917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Micronized Purified Flavonoid Fraction Therapy on Endothelin-1 and TNF-α Levels in Relation to Antioxidant Enzyme Balance in the Peripheral Blood of Women with Varicose Veins.
    Pietrzycka A; Kózka M; Urbanek T; Stpniewski M; Kucharzewski M
    Curr Vasc Pharmacol; 2015; 13(6):801-8. PubMed ID: 26311575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the role of angiogenesis in systemic lupus erythematosus.
    Liu J; Wang X; Yang X; Yan Q; Wang S; Han W
    Lupus; 2015 May; 24(6):621-7. PubMed ID: 25359881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microcirculation end effect of detralex in patients with chronic venous insufficiency of the lower extremities].
    Sirotin BZ; Zhmerenetskĭ KV
    Angiol Sosud Khir; 2003; 9(3):60-5. PubMed ID: 14657934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: predominance of vascular endothelial growth factor.
    Campbell CL; Savarese DM; Quesenberry PJ; Savarese TM
    Int J Cancer; 1999 Mar; 80(6):868-74. PubMed ID: 10074920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
    Kakkos SK; Nicolaides AN
    Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous elasticity after treatment with Daflon 500 mg.
    Ibegbuna V; Nicolaides AN; Sowade O; Leon M; Geroulakos G
    Angiology; 1997 Jan; 48(1):45-9. PubMed ID: 8995343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving venous symptoms in C0s-C1s patients after multicomponent diosmin-based preparation: Initial experience.
    Greco M; Bissacco D
    Phlebology; 2023 Jun; 38(5):348-351. PubMed ID: 36999205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioflavonoids and their significance in angiology: focus on diosmin].
    Bogachev VIu; Golovanova OV; Kuznetsov AN; Shekoian AO
    Angiol Sosud Khir; 2013; 19(1):73-81. PubMed ID: 23531663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.